Benefit of systemic therapy in MINDACT patients with small, ER-positive, HER2-negative breast cancers.
Hilbers FS, Poncet C, Tryfonidis K, Viale G, Delaloge S, Pierga JY, Brain EGC, Rubio IT, Thompson AM, Rutgers EJT, Piccart MJ, van 't Veer LJ, Cardoso F.
Hilbers FS, et al. Among authors: rubio it.
NPJ Breast Cancer. 2024 Nov 2;10(1):97. doi: 10.1038/s41523-024-00670-2.
NPJ Breast Cancer. 2024.
PMID: 39488549
Free PMC article.